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Abstract Limited efficacy of current first-line treatment for
leukemia calls attention for further development of efficient
strategies. Recently, much attention has been given to
nanoparticle-based drug delivery systems loaded with dual
drugs to improve current disease therapies by overcoming
toxicity. In the present study, we document to explore an
approach to conjugate gold nanoparticles (GNPs) with protein
toxin (NKCT1), a protein toxin from the Indian cobra (Naja
kaouthia) venom, and to establish its antileukemic activity.
GNP was prepared by NaBH4 reduction method. UV–vis
spectroscopy of GNP showed the absorbance at 530 nm for
plasma resonance. Dynamic light scattering (DLS) size of
GNPs was 2–8 nm and the GNP-NKCT1 was 68–122 nm.
CD spectra of GNP-NKCT1 showed change in percentage of
β-turn as compared with NKCT1. GNP-NKCT1 significantly
inhibited leukemic cell growth in dose- and time-dependent
manner by two- to threefold more than NKCT1. For human
leukemic lymphoma cell line and human myelogenous leuke-
mic cell line, the IC50 dose was found to be 1.2 and 0.
75 μg/ml, respectively, observed by trypan blue exclusion
method and tetrazolium bromide reduction assay. Flow
cytometric analysis showed appreciable number of both cell
lines in early and late apoptotic stages and arrested cell cycle
in the G1 phase by GNP-NKCT1. Resilient power of leuke-
mic cell line after wound healing and migration or invasive
power of the cell line was significantly low in GNP-NKCT1-
treated plate than the control plate. These analyses reveal that
GNP-NKCT1 possesses significant and selective anticancer
activity, likely by inducing programmed cell death through
mitochondrial and/or lysosomal pathway.
Keywords GNP-NKCT1 . Nanoparticle . Leukemic cell .
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1 Introduction
Snake venoms contain a wide range of proteins and peptides
(90–95 %), amino acids, nucleotides, free lipids, carbohy-
drates, and metallic elements bound to proteins (5 %). Snake
venoms contain a large number of biologically active pro-
teins and peptides that are usually similar in structure but not
identical to that of prey physiological systems (de Lima et
al. 2005; Heise et al. 1995; Tu 1988).
After discovery of “anticancer” activity of snake venom
(Naja sp.) by Calmette et al. (1933), a number of studies has
been carried out on anticancer activity on venom (Gomes et al.
2007; Zhang and Cui 2007; Chiu et al. 2009). Cancer, despite
of the all-out efforts from developed countries still causes one
in five deaths. Surgery, chemotherapy, and radiotherapy pro-
vide inadequate protection and instead affect normal cells along
with cancer cells. The search for cancer cure from natural
product (plants and animals) has been practiced for over a
century and the use of purified chemicals to treat cancer still
continues. From the 1940s to 2007, of the 155 new cytotoxic
molecules developed, 47 % are actually either natural product
or directly derived from them. Several studies have been un-
dertaken during last three decades to establish the anticancer
property of venoms and toxins (Gomes et al. 2010). These lead
to the discovery of several promising molecule having antican-
cer activity, some of which are in clinical trial andmay emerged
to be a future drug in cancer therapy. In our earlier studies, we
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have established the anticancer/cytotoxic effect of a lethal
protein toxin NK-CT1 present in Indian monocellate cobra,
Naja kaouthia (Debnath et al. 2010). Recently, Biswas et al.
reviewed potential venoms and toxins along with nanoparticle-
conjugated venom toxins of snake, amphibians, and bees, etc
for possible therapeutic clues against emerging disease (Biswas
et al. 2012). The present study reports the increasing efficien-
cies of anticancer/cytotoxic activity of protein toxin NK-CT1
conjugating with gold nanoparticles.
Present-day nanomedicine exploits carefully a broad va-
riety of structured nanoparticles. These nanoparticles may
serve as diagnostic and therapeutic antiviral, antitumor, or
anticancer agents (Faraji et al. 2009; Ghosh et al. 2008; Hu
and Zhang 2012; Tiwari et al. 2011). The determinant suc-
cess in therapeutic and diagnostic use of nanoparticle (NP)
is the ability to deliver them to desired target. In this sense,
NP can be conjugated with biological molecules to make
them recognize the biological target. From the point of view
of molecular recognition, proteins have a number of prop-
erties participating in ligand–receptor and protein–protein
molecular interactions. Gold is used for nanoparticle appli-
cations because it is unreactive and is not sensitive to air or
light. However, gold does like to form bonds with itself and
for this reason their surfaces have to be covered with a layer
of protective molecules, for example polyethylene glycol
(PEG). Capping GNP with PEG could increase stability
and biocompatibility. The aim of this work was to explore
the conjugation of protein toxin (NKCT1) on GNP surface
and characterization of GNP-NKCT1 and their stability. The
purpose was to increase the anticancer activity of GNP-
NKCT1 from the native protein toxin NKCT1.
2 Materials and methods
2.1 Chemicals
Acrylamide, bis acrylamide, Coomassie brilliant blue, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), sodium dodecyl sulfate (SDS), sodium bicarbonate
(NaHCO3), ethidium bromide, RNase A, sodium borohydrate,
carboxymethyl (CM) cellulose, propium iodide, acridine or-
ange, trypan blue, hydrogen tetrachloroaurate (III) trihydrate,
and de-methoxy sulphoxide (DMSO) were purchased from
Sigma-Aldrich Co. (St. Louis, MO, USA). RPMI1640 medi-
um, fetal bovine serum, and penicillium–streptomycin was
purchased from Invitrogen (USA). Annexin V-FITC, cell
cycle kit, FITC-5-bromo-2′-deoxyuridine (BrdU) kit, and
Ki-67 antihuman antibody kits were purchased from BD-
Bioscience, USA. All other chemicals were purchased locally
and were of analytical grade. Lyophilized N. kaouthia crude
venom was purchased from Calcutta Snake Park, Kolkata,
India.
2.2 Purification of protein toxin NKCT1
NKCT1 protein toxin was purified by ion-exchange column
chromatography using CM cellulose and further purified by
high-performance liquid chromatography (HPLC; Debnath et
al. 2010). The fraction was desalted and concentrated by
Centricon (Millipore MWCO 3 k). Purified NKCT1 was
checked by SDS-polyacrylamide gel electrophoresis (PAGE)
gel electrophoresis method (Laemmli 1970).
2.3 Synthesis of gold nanoparticles and conjugation
of NKCT1
The gold nanoparticles were prepared by sodium borohy-
dride reduction method (Samal et al. 2010) with modifica-
tions. The synthetic method developed for this experiment
consistently produces stable gold nanoparticles provided the
conditions are properly controlled. A 25 ml conical was well
washed with aqua regia and dried. HAuCl4 (20 mM) and
PEG (10 mg/ml) were mixed with sterile phosphate buffer
(Liu et al. 2007). Then 100 mM NaBH4 was added dropwise
into the conical which was placed on magnetic stirrer at
37 °C for 1 h (pH 7.2). Just after mixing the NaBH4, the
color of the reaction mixture was light violet and after
several minutes, it changed to deep blue. After 1 h of
stirring, mixture is centrifuged at 8,000 rpm for 30 min.
Pellet containing large nanoparticles was discarded and
1 mg/ml of protein toxin NKCT1 was added into the
supernatant and suspension was kept at room 37 °C for
proper conjugation (Table 1).
2.4 Structural characterization of GNP-NKCT1
Conjugation was confirmed by running the 12 % PAGE gel
electrophoresis along with low-range molecular marker. CD
spectroscopy of the NKCT1 and GNP-NKCT1 was done
using Jasco J-815 Circular Dichromism spectrometer with a
0.1-cm cuvette at 25 °C for determination of change in sec-
ondary structure of native protein toxin upon its conjugation
(Liu et al. 2007; Higuchi et al. 2007).
2.5 Biophysical characterisation of GNP-NKCT1
UV–vis spectroscopy (Perkin Elmer, Lambda-25) measure-
ments from 200 to 700 nm and 400 to 700 nmwere performed
for NKCT1, GNP-NKCT1, and GNPs only. Spectra were
taken at room temperature with 1 cm optical length cuvette
with special resolution of 1 nm (Sobczak-Kupiec et al. 2011;
Bhattacharya and Srivastava 2003; Olmedo et al. 2008; Sau et
al. 2001; Zubarev et al. 2006). Dynamic light scattering mea-
surements were performed in a Malvern Zetasizer Nano ZS
apparatus (Malvern Instruments, Milan, Italy) at 25 °C and
started 2 min after the cuvette was placed in the dynamic light
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scattering (DLS) apparatus to allow the temperature to equil-
ibrate. Measurement was carried out 24 h after the preparation
of conjugation (Sobczak-Kupiec et al. 2011). The TEM image
was obtained on a JEOL JSM 1100 transmission electron
microscope. A drop of sample solution was allowed to dry
on copper grid overnight (Sau et al. 2001; Zubarev et al.
2006). Atomic force microscope (AFM) image was taken
using Atomic Force Microscope (Park System, XE-70,
South Korea) in a dark room at 25 °C in noncontact mode
for confirmation of nanoparticle and conjugate size (Abdullin
et al. 2009).
2.6 Cell culture
Human leukemic lymphoma cell line (U937) and human
myelogenous leukemic cell line (K562) were provided by
Dr. Aparna Gomes, Scientist, Indian Institute of Chemical
Biology, Calcutta, India. Cells were cultured in RPMI 1640
supplemented with 10 % heat-inactivated fetal bovine serum
(FBS), NaHCO3 (1.5 g/L), penicillin (100 units), and strepto-
mycin (10 μg/ml). Cells were grown to confluence at 37 °C in
a humidified atmosphere of 5 % CO2 inside an incubator
(Heal Force, China).
2.7 Separation and culture of normal lymphocytes
Blood was collected aseptically from the vein of healthy
adults (aged 24–30), after informed consent, and transferred
to heparinised vial. Lymphocytes were collected from whole
blood using Ficoll histopaque after proper dilution with
autoclaved saline water (Giri et al. 2006). Then, it was washed
with 1× phosphate-buffered saline (PBS) and cultured in
sterile complete RPMI 1640 media. Cells were grown in a
CO2 incubator at 37 °Cwith 5%CO2 in humidified condition.
The experiment was approved by the institutional human
ethical committee (Ref. No. IHEC/AG/HUM/P17/12).
2.8 IC50 dose determination of GNP-NKCT1
2.8.1 Cell growth inhibition studies on leukemic cells
and normal lymphocytes
U937, K562 (1×106) were seeded in 96-well sterile
plates and were treated with different concentrations
(1–5 μg/ml for U937 cell and 0.5–2 μg/ml for K562
cell of GNP-NKCT1 (I, II, and III)) for 24 and 48 h of
incubation. Normal lymphocytes (1×106) were also
seeded on 96-well and treated with IC50 dose of cell
lines with respect to standard drug imatinib mesylate
(10 μg/ml). The cell growth inhibition studies were
done using 0.2 % trypan blue with direct count under
light microscope (Olympus, Tokyo) using hemocytome-
ter chamber (Debnath et al. 2010).
2.8.2 Cytotoxicity studies on leukemic cells and normal
lymphocytes
Exponentially growing U937 and K562 cells and freshly
collected normal lymphocytes at a cell density of 1×106/ml
were incubated with different concentrations (1–5 μg/ml for
U937 cell and 0.5–2 μg/ml for K562 cell IC50 dose of both
cell line and imatinib mesylate (10 μg/ml for normal lympho-
cytes)) of GNP-NKCT1 (I, II, and III) for 24 and 48 h at
culturable conditions at CO2 incubator. MTT assay of treated
cells were done to confirm its cytotoxic effect (Sargent and
Taylor 1989). Of the MTT solution, 40 μl (5 mg/ml) was
added 4 h prior to the end of 24 and 48 h of incubation. The
formazan granules formed by viable cells were dissolved in
DMSO and the absorbance at 570 nm was estimated by
measuring with an ELISA reader (BioTek, ELx800).
2.9 Morphological studies for detection of apoptosis
2.9.1 Florescence microscope studies
U937 and K562 cells (1×106) treated with IC50 dose of
GNP-NKCT1 (respective of two cell lines) for 24 h
were observed using a fluorescence microscope for mor-
phological changes. The untreated control cells and the
GNP-NKCT1-treated cells were harvested separately,
washed with PBS, and then stained with acridine orange
(100 μg/ml) and ethidium bromide (100 μg/ml, 1:1; Das
et al. 2011). The cells were then immediately mounted
on slides and observed under fluorescence microscope
(Motic Image plus 2.0 software) for determination of
the cells undergoing apoptosis.
2.9.2 Confocal microscopic studies
Leukemic cells (1×106) were treated with IC50 dose of GNP-
NKCT1 for 24 h. After 24 h, the untreated control and treated
cells were pulled out and washed with ice-cold PBS. The cell
Table 1 Three different types
gold nanoparticle conjugated
NKCT1 and their composition
of different chemicals
Type HAucl4 (20 mM) PBS (1×) PEG (10 mg/ml) NaBH4 (100 mM) NKCT1 (1 mg/ml )
GNP I 200 μl 8,000 μl 80 μl 40 μl 832 μl
GNP II 240 μl 6,240 μl 62.4 μl 40 μl 1,000 μl
GNP III 360 μl 5,760 μl 57.6 μl 60 μl 612 μl
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was then stained with 10μg/ml ethidium bromide and 5μg/ml
of 4′,6-diamidino-2-phenylindole (DAPI), respectively, on L-
lysine-coated slide for 5 min (Roy et al. 2008). After mounting
on slides, the cells were observed to show the differences in
nuclear morphology between the untreated and GNP-
NKCT1-treated cells under confocal laser scanning micro-
scope (Leica TCS-SP2 system). Image for ethidium bromide
and DAPI were acquired from argon/krypton laser and UV
laser line using 590 nm long-pass filter for ethidium bromide,
488 nm long-pass filter for DAPI, and 450 nm bandpass filter
for UV images.
2.10 Wound-healing assay
Cells were grown to 99 % confluence in six-well plate at
37 °C of 5 % CO2 incubator. A wound was created by
scratching cells in 1.5-cm zone with sterile 200-μl pipette
tip after the old medium was washed out. Then, cells were
incubated in newly added sterile medium in the absence or
presence of GNP-NKCT1 for 24, 48, and 72 h. Cell migra-
tion into wound surface was determined under an inverted
microscope (Labomed, India).
2.11 Detection of apoptosis by DNA fragmentation
and agarose gel electrophoresis
U937 and K562 cells (1×106) were treated with IC50
dose of GNP-NKCT1 for 24 h. The cells were
harvested and washed twice with PBS. The cells were
resuspended in 1 ml of digestion buffer (50 mM Tris-
HCl, pH 8.0, 10 mM EDTA, and 0.5 % SDS),
100 μg ml−1 of proteinase K was added and incubation
was done at 65 °C water bath overnight. DNA extrac-
tion was done by following the general phenol–chloro-
form extraction procedure. After centrifugation, the
upper layer was mixed with the same volume of
isoamyl alcohol. Again after centrifugation, DNA pre-
cipitates were washed with 70 % ethanol, dried, and
evaporated at room temperature and dissolved in TE
buffer (pH 8.0) at 4 °C overnight. To detect DNA frag-
ments, the isolated DNA samples were electrophoresed
overnight at 20 V in 1 % agarose gel and stained with
ethidium bromide (Roy et al. 2008). DNA fragmentation
was observed in UV transilluminator.
2.12 Detection of apoptosis by flow cytometric analysis
In order to investigate the type of cell death induced by
GNP-NKCT1, flow cytometric analysis was done by
performing dot plot assay (Debnath et al. 2010). The
leukemic cells (1×106) were treated with IC50 dose and
3/4 of IC50 dose for 24 h. The cells were pelleted
down, centrifuged at 2,000 rpm for 10 min at 4 °C,
and washed with Annexin V-FITC binding buffer
(10 mM HEPES, 140 mM Nacl, and 2.5 mM CaCl2,
2H2O; pH 7.4). Again after centrifuging at 2,000 rpm at
4 °C, cell pellets were dissolved in Annexin V-FITC
binding buffer containing Annexin V-FITC and
propidium iodide. After 15-min incubation in the dark
at room temperature, flow cytometric analysis was done.
All data were acquired with a Becton-Dickinson FACS
Verse double laser cytometer. Flow cytometric reading
was taken using 488 nm excitation and bandpass filters
of 527/32 nm (for FITC detection) and 585/42 nm (for
PI detection).
2.13 Study of cell cycle arrest by flow cytometric analysis
Of the leukemic cells, 1×106were treated with IC50 dose
and 3/4 of IC50 dose of GNP-NKCT1 for 24 h. Cells were
washed with PBS, fixed with ice-cold 70 % ethanol which
was added drop-wise in stirring condition on Vortex, and
kept at −20 °C overnight. Cells were pelleted down, washed
twice with cold PBS, and finally dissolved in PBS treated
with RNase A for 30 min at 37 °C and stained with propium
iodide (20 μl from 50 μg/ml) and kept in the dark for
15 min. Cell cycle phase distribution of nuclear DNA was
determined on FACS, fluorescence detector equipped with
488 nm laser light source and 623 nm bandpass filter (Hosta
et al. 2009; Lin et al. 2006).
2.14 Estimation of total DNA by Ki-67 antihuman antibody
using FACS
U937 and k562 cells (1×106) were treated with IC50 dose
and 3/4 of IC50 dose of GNP-NKCT1 for 24 h. Cells were
washed with PBS and fixed with ice-cold 70 % ethanol and
kept at −20 °C overnight. Cells were washed with buffer
(PBS with 1 % FBS, 0.09 % NaN3 pH 7.2) twice and the
cells were resuspended in PBS. Of the Ki-67 antibody cell,
20 μl/100 μl were added (Ross et al. 2003). After mixing
gently, it was kept for 20 min at room temperature in the
dark. After centrifugation at 1,000 rpm for 5 min, 500 μl of
PBS was dissolved and added to 10 μl (50 μg/ml) of PI
staining solution and incubated for 15 min at room temper-
ature in the dark. Then, the sample was analyzed with FACS
verse (BD Bioscience).
2.15 Estimation of replication cycle by BrdU incorporation
using FACS
Exponentially growing U937 and k562 cells (1×106) were
cultured on RPMI medium containing 10 μl BrdU
(10 μg/ml; Jayat and Ratinaud 1993; Holm et al. 1998).
After 1 h, cells were treated with IC50 dose and 3/4 of IC50
dose of GNP-NKCT1 and kept at CO2 incubator for 24 h.
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Cells were washed with PBS and fixed with permealization
buffer for 20 min. After washing again with PBS, Dnase
(5 μg/ml) was added and incubated for 1 h at 37 °C. Anti-
BrdU antibody was added to it and kept in the dark for
20 min after PBS washing. Incubated with 7-ADD for
15 min at dark condition, the sample was analyzed with
Fig. 2 Surface plasmon
resonance spectroscopy of
NKCT1 (λmax=220 nm) (c),
GNP (λmax=530 nm) (a) and
GNP-NKCT1 (both the
λmax=220 nm and λmax=
528 nm) (b) detected by
UV–Vis. Hydrodynamic
diameter of GNP and
GNP-NKCT1 were showed by
DLS. The size of only GNP was
2–8 nm with average size of
4 nm (d) and GNP-NKCT1
conjugate particle showed
68–122 nm with average of
92 nm (e)
Fig. 1 PAGE of conjugated sample.M marker, A and B GNP-NKCT1,
and C and D native NKCT1. Two types of conjugate were held (AB1,
14 kDa; AB2, 10 kDa). AB3 represents free protein (4–5 %) in
conjugated solution (a). CD spectra of secondary structure of NKCT1
upon its conjugation with GNP. b Graph presents the secondary struc-
ture of NKCT1 (23 % α helix, 19 % β sheet, and 35 % random coil). c
Graph presents the secondary structure of GNP-NKCT1 (43.5 % α
helix, 24.5 % β sheet and 32 % β turn)
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FACS verse using 507 nm long-pass filter, 527/32 bandpass
detector, and 488 nm laser light source.
2.16 Statistical analysis
All values are represented as arithmetic mean±SEM. Statistical
analysis was done by Student’s t test. A probability value of less
than 0.05 was chosen as the criterion of statistical significance.
3 Results
3.1 Purification of NKCT1
As previously reported by Debnath et al., NKCT1 was
purified by ion-exchange method and 3.24 mg/ml protein
was estimated by Lowry’s method (Lowry et al. 1951).
HPLC showed only a single peak with a retention time of
10 min. SDS-PAGE showed single band with molecular
weight of 6.7 kDa (Fig. 1a).
3.2 Conjugation of GNP with protein toxin NKCT1
Polyacrylamide gel electrophoresis of GNP-NKCT1
showed two bands as compared with the single band of
NK-CT1. Molecular weight of the two bands of GNP-
NKCT1 was found to be 10 and 14 kD, respectively
(Fig. 1a), unconjugated NK-CT1 (above 4–5 %) was present
and produced faint band in PAGE. CD spectra showed, native
NK-CT1 contained 23 % α-helix, 19 % β-sheet, and 35 %
random coil and GNP-NKCT1 contained 43.5 % α-helix, 24.
5 % β-sheet, and 32 % β-turn. Percent change after conjuga-
tion was found to be 20.5 % of α-helix, 5.5 % β-sheet. Found
in the secondary structure of GNP-NKCT1, 32 % of β-turn
Fig. 3 Transmission electron
microscopy (TEM) photograph
of goldnanoparticle
(bar 50 nm). Only GNP (a)
and GNP with protein core (b).
Arrow indicates protein core
around the GNP. Actual size
of gold nanoparticle measured
by atomic force microscope.
Where only GNP showed
5–25 nm (c), GNP-NKCT1
showed 40–220 nm (d)
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was found in the secondary structure of GNP-NKCT1 as
compared with the 35 % random coil of NK-CT1. This data
confirmed that cysteine/amide residue (Dolati et al. 2011) of
the amino acid chain was conjugated with gold nanoparticle
directly with the surface or via PEG attached with the GNP
surface (Fig. 1b and c).
3.3 Biophysical characterization of GNP-NKCT1
The gold nanoparticle formed was light violet/pink color
having plasmon resonance at 530 nm (Fig. 2a). The plasmon
resonance of GNP-NKCT1 was formed at the 528 and
220 nm, as compared with the plasmon resonance of NKCT1
which was at 220 nm (Fig. 2b and c). The hydrodynamic
diameter of the nanoparticle measurement with DLS was
found in the range of 2–8 nm, with an average size of 4 nm
(Fig. 2d). GNP-NKCT1 diameter was 68–122 nm, with an
average size of 92 nm (Fig. 2e). Figure 3 shows high-
resolution TEM micrograph (HR-TEM) of bare GNP and
NKCT1-coated GNP (Fig. 3a, b). The presence of layer
around the nanoparticle core was due to NKCT1, which
was observed by uranyl acetate staining. As observed, the
PEG and one/two protein molecule covered the whole surface
of the nanoparticle and increased the hydrodynamic size
Fig. 4 Bar diagram presents the IC50 dose of GNP-NKCT1 (1, 2,
and 3) on U937 cell line (a and b) and K562 cell line (c and d),
determined by trypan blue exclusion method. On U937 cell after
24 h IC50 dose=1.5 μg/ml (a) and after 48 h IC50 dose=1.2 μg/ml (b). On
K562 cell after 24 h. IC50 dose=0.8 μg/ml (c) and after 48 h IC50
dose=0.75 μg/ml (d). Result of MTT assay on U937 cell line
[e (24 h) and f (48 h)] and on K562 cell [g (24 h) and h (48 h)].
Effect of GNP-N KCT1 and imatinib mesylate on normal lym-
phocyte. Cell count by trypan blue exclusion (4i) and byMTTassays (4j).
Each value represents quadruplicate samples of mean±SEM. *P<0.05 as
compared to control
GNP-NKCT1 inhibits leukemia 45
of NKCT1-capped gold nanoparticle. AFM showed the
cluster of the gold nanoparticle size and it was found to
be 4–25 nm whereas with protein core, it was 45–225 nm
(Fig. 3c, d).
Fig. 4 (continued)
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3.4 Cell growth inhibition study and cytotoxicity study
GNP-NKCT1 at concentrations of 1–5 μg/ml (U937 cell line)
and 0.5–2 μg/ml (K562 cell line) significantly inhibited the
growth of the respective leukemic cells compared with the
control cell and normal lymphocyte cell in a time- and
concentration-dependent manner. Cell count (Fig. 4a–d) and
MTT assay (Fig. 4e–h) revealed that IC50 value for U937 and
K562 cells were 1.2 and 0.75 μg/ml of GNP-NKCT1-I only.
When normal human lymphocytes were treated with GNP-
NKCT1 (1.2 μg/ml) for 48 h, there was 15–16 % decrease in
count as compared to untreated control (Fig. 4i–j). But when
normal human lymphocyte were treated with standard drug
imatinib mesylate (10 μg/ml) for 24 h, there was 34–35 %
decrease in count (Fig. 4i–j). This showed that cell death after
GNP-NKCT1 treatment was significantly less in case of nor-
mal lymphocytes as compared to treated leukemic cells and
also in comparison to the standard imatinib mesylate, toxicity
of GNP-NKCT1 towards normal cells is less. The other two
conjugated product, GNP-NKCT1 (1) and GNP-NKCT1 (2)
did not show promising result. In U937 cells, IC50 dose were
3.0 and 2.8 μg/ml, respectively, for GNP-NKCT1-II and
GNP-NKCT1-III, whereas in K562 cells IC50 dose were
1 μg/ml and more than 1 μg/ml, respectively, for GNP-
NKCT1-II and GNP-NKCT1-III (Table 2). As GNP-
NKCT1-I showed very promising result, it was selected as
an experimental sample for rest of the experiment and it was
abbreviated GNP-NKCT1 only.
3.5 Morphological studies for detection of apoptosis
Morphological observations of treated cells from both the cell
lines under fluorescent microscope showed intact nuclei in
control cell that gave bright green fluorescence (Fig. 5a and c)
whereas treated cells showed intense orange–red fluorescence
showing signs of apoptosis (Fig. 5b and d). Confocal micro-
scopes revealed chromatin disintegration and formation of
apoptotic bodies (Fig. 5e, g, i, and k) whereas control cell
showed intact cell (Fig. 5f, h, j, and l).
3.6 GNP-NKCT1 inhibited leukemic cell migration
As shown in Fig. 6, the cell migration was obviously inhibited
by GNP-NKCT1 with time-dependent manner. Where control
cell (absence of GNP-NKCT1) showed growth in wound zone
within 24 h, the treated cell showed very little growth in
scratching zone after 48 h. After 72 h, 95.80 % control
U937 cells migrated in the wound zone but it was only 40.
88 % in treated U937 cell; in case of K562 cells where in 99.
10 % were filled, only 51.60 % were filled by treated cell.
3.7 Detection of apoptosis by DNA fragmentation
and agarose gel electrophoresis
The gel pattern of DNA samples isolated from untreated
control cell lines showed intact bands whereas the gel pat-
tern of DNA samples isolated from GNP-NKCT1-treated
U937 (Fig. 7a) and K562 cells (Fig. 7b) showed smeary
band. So, the observations confirmed that the treatment with
GNP-NKCT1 causes apoptosis in human leukemic cells.
3.8 Detection of apoptosis by flow cytometric analysis
In the flow cytometric analysis, lower left (LL) quadrant
(Annexin V–/PI–) is regarded as population of live cells, lower
right quadrant (LR; Annexin V+/PI−) is considered as the cell
population at early apoptotic stage, upper right quadrant (UR;
Annexin V+/PI+) represents the cell population at late apoptotic
stage and upper left quadrant (AnnexinV−/PI+) is considered as
necrotic cell population. Flow cytometric data analysis revealed
that after 24 h of treatment of GNP-NKCT1 (IC50 dose) 0.37 %
in LL quadrant, 57.16 % in LR quadrant, and 42.47 % in UR
quadrant of U937 cells (Fig. 8b) with respect to 98.51 % in LL
quadrant, 0.17% in LR quadrant, and 0.45% in UR quadrant of
control cell (Fig. 8a) and 22.27 % in LL quadrant, 75.89 % in
LR quadrant, and 1.81% inUR quadrant of K562 cells (Fig. 8d)
with respect to 96.37 % in LL quadrant, 2.95%in LR quadrant,
and 0.55 % in UR quadrant of control cell (Fig. 8c).
3.9 Study of cell cycle arrest by flow cytometric analysis
The flow cytometric analysis showed that when compared
with that of the untreated control U937 cells and K562 cells,
24 h of GNP-NKCT1 (3/4 of IC50 dose) treatment caused a
progressive increase in the number of cells with 2N DNA
content, indicating that the GNP-NKCT1 treatment inhibited
the growth of U937 and k562 cells by cell cycle arrest in G1
phase. Where U937-treated cell showed 78.58 % G1+G0, 6.
84 % S, and 8.81 % G2+M (Fig. 8f), the control cell showed
48.88 % G1+G0, 40.80 % S, and 8.98 % G2+M (Fig. 8e)
where k562 cells showed 62.47 % G1+G0, 31.62 % S, and 2.
98 % G2+ M (Fig. 8h), the control cell showed 35.84% G1+
G0, 50.03 % S, and 11.86 % G2+M (Fig. 8g).
Table 2 IC50 dose of GNP conjugated NKCT1 on leukemic cell lines
Cell line GNP type IC50 (μg/ml) of conjugated
GNP-NKCT1
24 h 48 h
U937 GNP-NKCT1-III 1.60±0.09 1.20±0.05
GNP-NKCT1-II 3.80±0.10 3.00±0.12
GNP-NKCT1-I 3.40±0.08 2.80±0.10
K562 GNP-NKCT1-III 0.80±0.07 0.75±0.03
GNP-NKCT1-II 1.10±0.06 1.00±0.05
GNP-NKCT1-I 1.25±0.07 1.20±0.01
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3.10 Estimation of total DNA by Ki-67 antihuman antibody
using FACS
The flow cytometer detected, DNA content of control cells
was much higher than the treated cell lines. In case of
control, U937 cell showed 97.06 % dividing phase and
control K562 cell showed 88.70 % (Fig. 9a and c), but in
treated cell line dividing cell were 46.11 and 65.68 %,
respectively (Fig. 9b and d). This result proved that control
cell showed more dividing phase (S phase and G2+M
phase) than treated cell line.
3.11 Estimation of replication cycle by BrdU incorporation
using FACS
The immunofluorescent staining of incorporated bromodeoxy
uridine (BrdU) and flow cytometry analysis provide a high-
resolution technique to determine the frequency and nature of
Fig. 5 Fluorescence microscopic images of control U937 (a), K562 (c),
GNP-NKCT1 treated U937 (b), treated K562 (d) cell line. The control
cells gave bright green fluorescence for their intact nuclei whereas both
treated cell line red fluorescence showing signs of apoptosis. Confocal
microscopic images of control U937 (e and i), K562 (g and k) and
GNP-NKCT1 treated U937 (f and j), treated K562 (h and l) cell lines.
The treated cells indicated apoptotic changes like nuclear disintegration,
membrane disruption. e–hCells stained with propium iodide and i to l are
cells stained with DAPI
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individual cells that have synthesized DNA. In this method,
BrdU (an analog of DNA precursor thymidine) is incorporated
into newly synthesized DNAby cells entering and progressing
through the S (DNA synthesis) phase of cell cycle. Often,
staining with a dye that binds to total DNA such as 7-ADD is
coupled with immunofluorescent BrdU staining. With this
combination, two-color combination and two-color flow
cytometry analysis permits the enumeration and characteriza-
tion of cells that are actively synthesizing DNA in terms of
their cell cycle position. BrdU incorporation via replication
cycle (synthesis phase) was significantly decreased in GNP-
NKCT1 treated cell with respect to control cell. Control U937
cell showed 54.04 % synthesis phase and GNP-NKCT1 treat-
ed cell showed 20.44 % (Fig. 9e and f). In other set of
experiment, GNP-NKCT1 treated K562 cell showed 50.7 %
BrdU incorporation with respect to 71.04 % of BrdU in
control K562 (Fig. 9g and h).
4 Discussions
The number of natural product-derived drugs present in the
total drug launches from 1940 to 2011 was recently analyzed
and it was concluded that natural products are still a significant
source of new chemotherapeutic agent, especially anticancer
(Newman et al. 2003). Although many chemotherapeutic
drugs are used clinically, the overall survival of leukemia
patients is far from satisfactory. Recent advances in nanotech-
nology have stimulated different applications in biomedicine
where nanoparticles are used as drug delivery vehicles
allowing rational manipulation of pharmacological profiles
of drugs encapsulated in them and hence their concomitant
therapeutic indices(Wang et al. 2009). The present investiga-
tion confirmed the increase of percentage of cytotoxicity
activity and apoptosis against two human leukemic cell lines
U937 and K562 including the conjugation of protein toxin
NKCT1 with gold nanoparticle. Gold nanoparticle has special
attraction to sulfur bond (Fan et al. 2003). Though protein
toxin NKCT1 has cysteine residue, we used PEG for more
stability of GNP-NKCT1. CD spectra showed the change in
secondary structure that might be the bonding of N-terminal
NH2 or internal amide group of NKCT1 via the hydroxyl
(OH) group of PEG with gold nanoparticle; still some work
(i.e., FTIR, XPS, EELS) should be done to investigate the
proper bonding of GNP with NKCT1 (Liu et al. 2007; Shi et
al. 2004). UV–vis spectroscopy showed surface plasmon res-
onance at 520–540 nm which is the primary characteristics of
gold nanoparticle formation (Triulzi et al. 2008). For using of
strong reducing agent like sodium borohydrate for the prepa-
ration of GNP, it became very much polydisperse in size. The
formation of GNPs by NaBH4 and sodium citrate method was
different. In sodium citrate method, after formation of GNPs,
it became capped by citrate ion that is why they repelled each
other and stayed single in solution. But in NaBH4 method,
they became as Au 0 state that is why they attracted each other
and formed the cluster of GNPs with time-dependent manner.
Where HR-TEM confirmed the formation of various size of
gold nanoparticle formation, PAGE gel electrophoresis
showed molecular weight became 10 to 14 kDa which means
one or two protein chains were conjugated per gold nanopar-
ticle. The GNP-NKCT1 is stable at room temperature and
showed the same efficiency effect after 1 month of storing at
Fig. 5 (continued)
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room temperature (30o±5 °C); GNP not only increases the life
span of NKCT1. Our study emphasize on the already
established fact that GNP-NKCT1 were taken up more by
leukemic cell in comparison to native protein NKCT1. The
lower uptake of native NKCT1 is attributed to the resistance
experienced by them due to P-gp pump highly expressed on
leukemia cells (Hui et al. 2008) which acts as an energy drug
efflux pump and leads to decrease in cytotoxic protein accu-
mulation. The nanoparticle conjugation system escapes the P-
gp pump as their uptake is mediated by specific endocytic
processes (Sahoo and Labhasetwar 2005). Thus, gold
nanoparticle-conjugated NKCT1 preferentially delivered into
the cells or subcellular organelle like mitochondria or lyso-
some for eliciting a better therapeutic effect than native protein
NKCT1. The antiproliferative and the cytotoxic activities of
GNP-NKCT1 were supported by observations in cell growth
inhibition studies and in MTT assays, respectively. GNP-
NKCT1 inhibited the growth and electron transport chain
via blocking of succinate dehydrogenase in mitochondria of
U937 and K562 cells in concentration- and time-dependent
manner. In separate study, we saw GNP-NKCT1 possesses
potent immunomodulatory activity and that concentrations
(IC50 dose of U937 cell) showed very less toxic effect on
normal lymphocyte cell line as observed by trypan blue ex-
clusion and MTT assay. This finding reveals that GNP-
NKCT1 preferentially acts on leukemic cells. Competency
of drug-loaded nanoparticles in inhibiting the growth of
K562 cells were recently studied by Palma et al., where
imatinib-loadedmicrocapsules were used to targeted leukemia
stem cells more profoundly than native imatinib (Palma et al.
2010). Similar approach was also taken up by Luo et al. and
Yang et al. who have used N succinyl chitosan nanoparticles
and lipid nanoparticles on K562 cells for better antitumor
effect (Luo et al. 2009; Yang et al. 2009).
There are two main strategies by which chemotherapeutic
agents are capable of exerting their effect: (1) is by induction
of apoptosis and (2) is by cell cycle inhibition. Many of the
compounds under study as antitumor agents act at multiple
steps in cell cycle, and their effects may be cytostatic or
cytotoxic, depending on the cell cycle status of the target cells
(Shapiro andHarper 1999). In this context, our study indicated
that at lower concentration (0.5μg/ml for K562 cell line and 0.
9 μg/ml for U937 cell line) of GNP-NKCT1 was able to cause
cell cycle arrest at particular phase while at a higher
concentration (0.75 μg/ml for K562 cell line and 1.
2 μg/ml for U937 cell line) it was capable of inducing
apoptosis. Central dogma of the cell was inhibited by
the treatment of GNP-NKCT1. BrdU, which is the an-
alog of the DNA precursor thymidine, is incorporated
during the first major round of cell cycle activity. Flow
cytometry detected inhibition of replication as treated
Fig. 7 The gel pattern of DNA samples isolated from a control U937
cells (2), treated U937 cells (1), b control K562 cells (1) and treated
K562 cells (2). Treated with GNP-NKCT1 showed smeary band of
DNA in both cell lines indicating the process of apoptosis
Fig. 6 Migration of both cell
lines was affected by
GNP-NKCT1. Only 40.88 and
51.60 % cells were recovered
after scratching in U937 and
K562 cell line, respectively.




Fig. 8 Flow cytometry analysis of U937 and K562 cells stained with
Annexin V-FITC-PI, after treatment with NK-CT1. Control U937 cells
(a), treated U937 cells (b), control K562 cells (c), and GNP-NKCT1
treated K562 (d). Flow cytometry analysis of cell cycle of untreated
control U937 cells (e), GNP-NKCT1-treated U937 (f), control K562 cells
(g), and treated K562 cells (h). Histogram of both the treated cell line
showed the arrest of cell cycle in G1 phase (x-axis denotes fluorescence
intensity of propium iodide and y-axis denotes cell count)
b
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cell showed less BrdU signal in synthesis phase. Similar work
was done by Ghiringhelli et al. where they measured the
incorporation of BrdU into T reg cells residing in tumor beds
and lymphoid organs of TFM versus tumor-bearing mice
(Ghiringhelli et al. 2005). Protein expression on the nuclear
surface became less as detected by ki-67, a nuclear prolifera-
tion associated antigen expressed in all active stages of the
cell. After GNP-NKCT1 treatment, cell cycle arrest as well as
Fig. 9 Flow cytometry analysis of DNA content of control U937 (a),
treated U937 (b), control K562 (c), and treated K562 (d) cells. Contour
plot of both treated cell line showed less number of nuclear proliferation-
associated protein (x-axis DNA content and y-axis fluorescence intensity
of FITC). Flow cytometry analysis of replication cycle of control U937
(e), GNP-NKCT1 treated U937 (f), control K562 (g), and GNP-NKCT1
treated K562 (h) cell lines. Control cells showed more BrdU incorpora-
tion by indicating more synthesis phase, whereas treated cell line showed
less BrdU incorporation indication less synthesis phase and signs of cell
cycle arrest
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programmed cell death occurred via apoptosis and for this
reasonmigration of cell became very less after wound healing.
Apoptosis is an important continuous and highly regulated
cellular process resulting in destruction of undesirable cells
during development or homeostasis in multicellular organisms
(Kaufmann and Hengartner 2011). Apoptogenic activity of
GNP-NKCT1 was investigated by different morphological
studies like fluorescence microscopic, confocal microscopic,
and phosphatidylserine externalization studies. The process of
apoptosis is characterized by several morphological changes
such as membrane blebbing, chromatin condensation, and
nuclear fragmentation. Fluorescence microscopic image clear-
ly showed nuclear disintegration of GNP-NKCT1-treated leu-
kemic cells compared with control cell when stained with
acridine orange and ethidium bromide. The control cells
showed bright green fluorescence as the live cells with intact
membrane excluded ethidium bromide and only acridine
orange could enter into them. On the contrary, GNP-NKCT1-
treated cells showed more intense red fluorescence and
reduced green fluorescence since apoptotic and necrotic cells
could not exclude the dyes and gave a combination of orange–
red fluorescence. Apoptogenic activity of GNP-NKCT1 was
further evidenced from the confocal microscopy images of
treated leukemic cells when compared to control cell. After
GNP-NKCT1, leukemic cell lines showed several signs of
apoptosis like chromatin condensation and nuclear fragmenta-
tion whereas the untreated control cells were with intact nuclei.
Externalization of PS from inner leaflet to outer leaflet of the
membrane is the hallmark of apoptosis. Externally translocated
PS bind with Annexin V in a calcium-dependent manner. Flow
cytometry detected Annexin V-FITC and showed the dot plot
supporting the fact that treatment with GNP-NKCT1-induced
apoptosis in the leukemic cells. Cells undergoing apoptosis
usually exhibited fragmentation of the cell into membrane-
bound apoptotic bodies, nuclear and cytoplasmic condensation,
and endolytic cleavage of the DNA into small oligonucleosomal
fragments (Thatte et al. 2000). Further evidence in support of
apoptogenic activity of GNP-NKCT1 was obtained from gel
patterns of agarose gel electrophoresis. GNP-NKCT1 showed
smeary bands, a typical indication of apoptosis whereas the
untreated control cells showed intact DNA bands. Apoptosis
is a tightly regulated process, which involves changes in
expression of distinct set of genes. Two of the major genes
responsible for regulating the mitochondrial apoptosis path-
way are antiapoptic Bcl-2 and proapoptic bax (Tong et al.
2004). Debnath et al. reported that NKCT1-induced the apo-
ptosis in leukemic cell line like U937 and K562 via activation
of Bcl2: bax and cleaved PRAP levels with increasing dose of
NKCT1. We also believed that our conjugated GNP-NKCT1
follow the same signaling pathway. Further work is going on
molecular signaling.
5 Conclusion
This study exhibited that conjugation of gold nanoparticle with
NKCT1 work in synergistic manner lowering both dose of
administration and time of action of the NKCT1 ensuring that
GNP release the NKCT1 to the target cell by controlled man-
ner and two- to threefold increase the cytotoxic effect while
minimizing the toxic effect of NKCT1. This conjugation was
capable of showing high antileukemic activity by inducing cell
cycle arrest and promoting apoptosis regulating activities like
nuclear fragmentation. Moreover, regulation of various bio-
chemical pathways after inhibiting the transcriptional and
translational level by GNP-NKCT1 treatment supports the
evolving concept that such nanoparticle conjugation may be
helpful for leukemia therapy in the near future.
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